MedTalks

top of page

FC Global Strategies.png

Strategists and Implementers
for growing companies globally

Subscribe to Our Newsletters

Disclaimer & DIsclosure

Recent Postings

MedTalks - An interview with Brian Frenzel, CEO of TOSK discussing the company's business and its investment opportunities

Jul 1, 20241 min read

MedTalks - An interview with Brian Frenzel, CEO of TOSK discussing the company's business and its investment opportunities

TK-90 has completed “proof of concept” in Phase 2a clinical studies demonstrating safety and efficacy in head and neck cancer patients...

MedTalks Video: NanoHive Medical's investment opportunity

Apr 29, 20242 min read

MedTalks Video: NanoHive Medical's investment opportunity

NanoHive Medical's revenues exceeded $3.5 million for 2023, are projected to exceed $6 million for this yearand exceed $10 million for 2025.

bottom of page